4 Biotech Stocks on the Move

These four biotech stocks have been moving on some interesting news and clinical results.
Publish date:

Cempra (CEMP)  is up 46% to $4.65 per share. They Announced top line results from a phase three clinical trial of its fusidic acid, which is used for treating skin infections. The Gains were not enough to cover an 82% loss in the past year.

Incyte (INCY) - Get Report  is up 5% to $128.10 per share. The stock is up on news that the company will join the S&P 500.

Achillion Pharma (ACHN) - Get Report  Shares fell 5.66% on Friday. In its Q4 filing the company reported a loss of $4.4 million.

Inovio (INO) - Get Report  Up 4.5% to $6.90 at the close on Thursday. The gains come after reporting positive clinical data on its Zika vaccine

This article was written by a staff member of TheStreet.